Reimann-Weber A, Horwath J, Höglinger A, Binder A, Kotanko P, Kenner Th, Skrabal F (1994): Charakterisierung von Allelen des humanen β2 Adrenozeptors. Nieren- und Hochdruckkrankheiten 23: S246-249.
Kotanko P, Höglinger O, Binder A, Skrabal F (1995): Further evidence for reduced β2 adrenoceptor expression and modification of its density at a level beyond gene expression. Diabetologia 38: 126-128.
Kotanko P, Binder A, Skrabal F (1995): Alleles of the human β2 adrenoceptor and their relationship to salt sensitivity. 7th European Meeting on Hypertension, Milan, 9th-12th June 1995, Book of abstracts, p 97.
Rahman SU, Quing F, Rhodes CG, Kotanko P, Binder A, Ind PW, Jones T, Hughes JMB (1996): Quantification of pulmonary β-adrenergic receptor (b-AR) downregulation in vivo with PET and correlation with functional tachyphylaxis and b-AR genotypes. Eur Resp J 9(suppl 23): 271s.
Kotanko P, Binder A, Tasker J, DeFreitas P, Kamdar S, Clark AJL, Skrabal F, Caulfield M (1997): Essential hypertension in African Caribbeans is associated with the Gly 16 allele of the β2 adrenoceptor. Ethnicity & Diasease 7(Suppl 1): S6.
Kotanko P, Binder A, Tasker J, DeFreitas P, Kamdar S, Clark AJL, Skrabal F, Caulfield M (1997): Essential hypertension in African Caribbeans associates with a variant of the β2 adrenoceptor. Hypertension 30:773-776.
Gratze G, Fortin J, Labugger R, Binder A, Schöner Th, Kotanko P, Busjahn A, Höhe M, Luft FC, Skrabal F (1998): Reduced β2-mediated whole body vasodilation in subjects with the Gly16-allele of the β2-adrenoceptor gene. J of Hypertens 16(S2):422.
Gratze G, Fortin J, Labugger R, Binder A, Kotanko P, Busjahn A, Höhe M, Luft FC, Skrabal F (1999): β2 adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilatation in normotensive Caucasians. Hypertension 33(6):1425-1430
© 2001 Alexander Binder